Literature DB >> 26565914

Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.

Thomas Bertero1, Katherine A Cottrill1, Yu Lu1, Christina M Haeger2, Paul Dieffenbach2, Sofia Annis1, Andrew Hale1, Balkrishen Bhat3, Vivek Kaimal3, Ying-Yi Zhang1, Brian B Graham4, Rahul Kumar4, Rajan Saggar5, Rajeev Saggar6, W Dean Wallace5, David J Ross5, Stephen M Black7, Sohrab Fratz8, Jeffrey R Fineman9, Sara O Vargas10, Kathleen J Haley2, Aaron B Waxman2, B Nelson Chau3, Laura E Fredenburgh2, Stephen Y Chan11.   

Abstract

Pulmonary hypertension (PH) is a deadly vascular disease with enigmatic molecular origins. We found that vascular extracellular matrix (ECM) remodeling and stiffening are early and pervasive processes that promote PH. In multiple pulmonary vascular cell types, such ECM stiffening induced the microRNA-130/301 family via activation of the co-transcription factors YAP and TAZ. MicroRNA-130/301 controlled a PPAR?-APOE-LRP8 axis, promoting collagen deposition and LOX-dependent remodeling and further upregulating YAP/TAZ via a mechanoactive feedback loop. In turn, ECM remodeling controlled pulmonary vascular cell crosstalk via such mechanotransduction, modulation of secreted vasoactive effectors, and regulation of associated microRNA pathways. In vivo, pharmacologic inhibition of microRNA-130/301, APOE, or LOX activity ameliorated ECM remodeling and PH. Thus, ECM remodeling, as controlled by the YAP/TAZ-miR-130/301 feedback circuit, is an early PH trigger and offers combinatorial therapeutic targets for this devastating disease.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26565914      PMCID: PMC4644508          DOI: 10.1016/j.celrep.2015.09.049

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  39 in total

1.  Roles for microRNAs in the regulation of cell adhesion molecules.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  J Cell Sci       Date:  2011-04-01       Impact factor: 5.285

2.  MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.

Authors:  Victoria N Parikh; Richard C Jin; Sabrina Rabello; Natali Gulbahce; Kevin White; Andrew Hale; Katherine A Cottrill; Rahamthulla S Shaik; Aaron B Waxman; Ying-Yi Zhang; Bradley A Maron; Jochen C Hartner; Yuko Fujiwara; Stuart H Orkin; Kathleen J Haley; Albert-László Barabási; Joseph Loscalzo; Stephen Y Chan
Journal:  Circulation       Date:  2012-02-27       Impact factor: 29.690

3.  Collagen and elastin metabolism in hypertensive pulmonary arteries of rats.

Authors:  G J Poiani; C A Tozzi; S E Yohn; R A Pierce; S A Belsky; R A Berg; S Y Yu; S B Deak; D J Riley
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

4.  Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

Authors:  Nils P Nickel; Edda Spiekerkoetter; Mingxia Gu; Caiyun G Li; Hai Li; Mark Kaschwich; Isabel Diebold; Jan K Hennigs; Ki-Yoon Kim; Kazuya Miyagawa; Lingli Wang; Aiqin Cao; Silin Sa; Xinguo Jiang; Raymond W Stockstill; Mark R Nicolls; Roham T Zamanian; Richard D Bland; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

Review 5.  Emerging therapies for the treatment of pulmonary hypertension.

Authors:  Kurt R Stenmark; Marlene Rabinovitch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

6.  Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.

Authors:  Devashish Kothapalli; Shu-Lin Liu; Yong Ho Bae; James Monslow; Tina Xu; Elizabeth A Hawthorne; Fitzroy J Byfield; Paola Castagnino; Shilpa Rao; Daniel J Rader; Ellen Puré; Michael C Phillips; Sissel Lund-Katz; Paul A Janmey; Richard K Assoian
Journal:  Cell Rep       Date:  2012-10-25       Impact factor: 9.423

7.  Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension.

Authors:  R P Mecham; L A Whitehouse; D S Wrenn; W C Parks; G L Griffin; R M Senior; E C Crouch; K R Stenmark; N F Voelkel
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

8.  Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension.

Authors:  Zhijie Wang; Naomi C Chesler
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

9.  Shear stress induced by an interstitial level of slow flow increases the osteogenic differentiation of mesenchymal stem cells through TAZ activation.

Authors:  Kyung Min Kim; Yoon Jung Choi; Jun-Ha Hwang; A Rum Kim; Hang Jun Cho; Eun Sook Hwang; Joong Yull Park; Sang-Hoon Lee; Jeong-Ho Hong
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.

Authors:  Nora Pencheva; Colin G Buss; Jessica Posada; Taha Merghoub; Sohail F Tavazoie
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

View more
  100 in total

1.  Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.

Authors:  Krishna C Penumatsa; Deniz Toksoz; Rod R Warburton; Mousa Kharnaf; Ioana R Preston; Navin K Kapur; Chaitan Khosla; Nicholas S Hill; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Mechanical forces rewire metabolism in the tumor niche.

Authors:  Thomas Bertero; Cedric Gaggioli
Journal:  Mol Cell Oncol       Date:  2019-03-25

3.  Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension.

Authors:  Shohini Ghosh-Choudhary; Stephen Y Chan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.

Authors:  Nathaniel C Bloodworth; Cynthia R Clark; James D West; J Caleb Snider; Christa Gaskill; Sheila Shay; Christine Scott; Julie Bastarache; Santhi Gladson; Christy Moore; Reid D'Amico; Evan L Brittain; Harikrishna Tanjore; Timothy S Blackwell; Susan M Majka; W David Merryman
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

5.  Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.

Authors:  Paul B Dieffenbach; Christina Mallarino Haeger; Anna Maria F Coronata; Kyoung Moo Choi; Xaralabos Varelas; Daniel J Tschumperlin; Laura E Fredenburgh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-06-22       Impact factor: 5.464

6.  Stephen Y. Chan: perseverance through criticism is essential for success in cardiovascular research.

Authors:  Brad Li
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

7.  YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.

Authors:  Yingzhun Chen; Xiaoguang Zhao; Jian Sun; Wei Su; Lu Zhang; Yingnan Li; Yingqi Liu; Lijia Zhang; Yanjie Lu; Hongli Shan; Haihai Liang
Journal:  Cell Death Differ       Date:  2019-01-15       Impact factor: 15.828

Review 8.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

Review 9.  Cellular Metabolism in Lung Health and Disease.

Authors:  Gang Liu; Ross Summer
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

Review 10.  Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension.

Authors:  Thenappan Thenappan; Stephen Y Chan; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.